High-resolution CT scanning: Potential outcome measure

Current Opinion in Pulmonary Medicine

Volumn 10, Issue 6, 2004, Pages 537-541

  Robinson, Terry E ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Composite CT PFT score; Cystic fibrosis; HRCT; Quantitative CT measurements

Indexed keywords

ANTIBIOTIC AGENT; COMPLEMENTARY DNA; DORNASE ALFA;

BRONCHIECTASIS; CLINICAL TRIAL; CYSTIC FIBROSIS; DISEASE SEVERITY; FORCED EXPIRATORY VOLUME; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; LUNG DISEASE; LUNG FUNCTION TEST; OUTCOMES RESEARCH; RADIOGRAPHY; REVIEW; SCORING SYSTEM; SPIROMETRY;

EID: 7444233593     PISSN: 10705287     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mcp.0000142924.38801.45     Document Type: Review

References (37)

1. Boucher RC: New concepts of the pathogenesis of cystic fibrosis lung disease. Eur Respir J 2004, 23:146-158.
2. Brody AS: Early morphologic changes in the lungs of asymptomatic infants and young children with cystic fibrosis. J Pediatr 2004, 144:145-146. This editorial describes the progressive nature of CF lung disease that begins very early in life and the need to appropriately address these lung changes with early intervention to preserve normal airway morphology.
3. + absorption produces cystic fibrosis-like lung disease in mice. Nature Medicine (Advance Online Publication) 11 April 2004; 1-7; doi:10.1038/nm1028.
4. Bhalla M, Turcios N, Aponte V, et al.: Cystic fibrosis: scoring system with thin-section CT. Radiology 1991, 179:783-788.
5. Nathanson I, Conboy K, Murphy S, et al.: Ultrafast computerized tomography of the chest in cystic fibrosis: a new scoring system. Pediatr Pulmonol 1991, 11:81-86.
6. Maffessanti M, Candusso M, Brizzi F, et al.: Cystic fibrosis in children: HRCT findings and distribution of disease. J Thorac Imaging 1996, 11:27-38.
7. Shah RM, Sexauer W, Ostrum BJ, et al.: High-resolution CT in the acute exacerbation of cystic fibrosis: evaluation of acute findings, reversibility of those findings, and clinical correlation. AJR Am J Roentgenol 1997, 169:375-380.
8. Santamaria F, Grillo G, Guidi G, et al.: Cystic fibrosis: when should high-resolution computed tomography of the chest be obtained? Pediatrics 1998, 101:908-913.
9. Helbich TH, Heinz-Peer G, Eichler I, et al.: Cystic fibrosis: CT assessment of lung involvement in children and adults. Radiology 1999, 213:537-544.
10. Helbich TH, Heinz-Peer G, Fleischmann D, et al.: Evolution of CT findings in patients with cystic fibrosis. AJR Am J Roentgenol 1999, 173:81-88.
11. Mason AC, Nakielna BE: Newly diagnosed cystic fibrosis in adults: pattern and distribution of bronchiectasis in 12 cases. Clin Radiol 1999, 54:507-512.
12. Brody AS, Molina PL, Klein JS, et al.: High-resolution computed tomography of the chest in children with cystic fibrosis: support for use as an outcome surrogate. Pediatr Radiol 1999, 29:731-735.
13. Demirkazik FB, Ariyurek OM, Ozcelik U, et al.: High resolution CT in children with cystic fibrosis: correlation with pulmonary functions and radiographic scores. Eur J Radiol 2001, 37:54-59.
14. Marchant JM, Masel JP, Dickinson FL, et al.: Application of chest high-resolution computer tomography in young children with cystic fibrosis. Pediatr Pulmonol 2001, 31:24-29.
15. Robinson TE, Leung AN, Northway WH, et al.: Spirometer-triggered high-resolution computed tomography and pulmonary function measurements during an acute exacerbation in patients with cystic fibrosis. J Pediatr 2001, 138:553-559.
16. Nasr SZ, Kuhns LR, Brown RW, et al.: Use of computerized tomography and chest x-rays in evaluating efficacy of aerosolized recombinant human DNase in cystic fibrosis patients younger than age 5 years: a preliminary study. Pediatr Pulmonol 2001, 31:377-382.
17. Oikonomou A, Manavis J, Karagianni P, et al.: Loss of FEV1 in cystic fibrosis: correlation with HRCT features. Eur Radiol 2002, 12:2229-2235.
18. Tiddens HA: Detecting early structural lung damage in cystic fibrosis. Pediatr Pulmonol 2002, 34:228-231. This review article contrasts lung function tests with high-resolution chest CT imaging in CF patients. Chest HRCT imaging in CF children reveals structural lung changes such as bronchial wall thickness that occurs early in the disease process and also demonstrates that there is a large amount of nonhomogeneity of progressive lung pathology. In addition, structural changes seen on HRCT such as bronchiectasis represent irreversible progressive damage, and pulmonary function tests, which are a measure of global function, cannot discriminate localized or early lung damage in the CF child.
19. de Jong PA, Ottink MD, Robben SG, et al.: Pulmonary disease assessment in cystic fibrosis: comparison of CT scoring systems and value of bronchial and arterial dimension measurements. Radiology 2004, 231:434-439. In this study, five different CF HRCT scoring systems were analyzed using thin-section CT scans obtained in 25 children with mild cystic fibrosis lung disease. All HRCT scoring systems were reproducible and had good interreader agreement. All five scoring systems also showed significant correlations with pulmonary function measurements and with the bronchus-artery diameter ratio, a marker for bronchiectasis severity.
20. de Jong PA, Nakano Y, Lequin MH, et al.: Progressive damage on high resolution computed tomography despite stable lung function in cystic fibrosis. Eur Respir J 2004, 23:93-97. This retrospective natural history study followed 48 CF children with annual PFTs and biennial HRCT scans over a 2-year period. Chest HRCT scores worsened over 2 years whereas PFTs remained unchanged or improved, suggesting that chest HRCT scoring is likely more sensitive than PFTs in detecting early and progressive lung changes in CF children.
21. Robinson TE, Leung AN, Northway WH, et al.: Composite spirometric-computed tomography outcome measure in early cystic fibrosis lung disease. Am J Respir Crit Care Med 2003, 168:588-593. This 1-year randomized, placebo-controlled study of inhaled dornase alfa in 25 CF children with mild obstructive lung disease revealed that composite total or maximal CT/PFT scores were more sensitive outcome measures for discriminating a treatment effect in children with mild CF lung disease than pulmonary function measurements or HRCT scores alone.
22. Brody AS, Klein JS, Molina PL, et al.: High-resolution compluted tomography in young patients with cystic fibrosis: distribution of abnormalities and correlation with pulmonary function tests. J Pediatr 2004, 145:32-38.
23. Long FR, Castile RG, Brody AS, et al.: Lungs in infants and young children: improved thin-section CT with a noninvasive controlled-ventilation technique-initial experience. Radiology 1999, 212:588-593.
24. Robinson TE, Leung AN, Moss RB, et al.: Standardized high-resolution CT of the lung using a spirometer-triggered electron beam CT scanner. AJR Am J Roentgenol 1999, 172:1636-1638.
25. Goris ML, Zhu HJ, Blankenberg F, et al.: An automated approach to quantitative air trapping measurements in mild cystic fibrosis. Chest 2003, 123:1655-1663. This comparative chest HRCT study, contrasting 25 children with mild CF lung disease with 10 age-matched normal controls, presents an automated approach to quantitative CT air trapping measurements. In this study, quantitative percent air trapping was a much more sensitive discriminator than global pulmonary function measurements for mild CF lung disease.
26. Moss RB, Rodman D, Spencer LT, et al.: Repeated adeno-associated virus serotype 2 aerosol-mediated cystic fibrosis transmembrane regulator gene transfer to the lungs of patients with cystic fibrosis: a multicenter, double-blind, placebo-controlled trial. Chest 2004, 125:509-521.
27. Lewiston NJ: Bronchiectasis in childhood. Pediatr Clin North Am 1984, 31:865-878.
28. McGuinness G, Naidich DP: CT of airways disease and bronchiectasis. Radiol Clin North Am 2002, 40:1-19.
29. Eastham KM, Fall AJ, Mitchell L, et al.: The need to redefine non-cystic fibrosis bronchiectasis in childhood. Thorax 2004, 59:324-327. This clinical and radiologic review evaluated 93 children with non-CF bronchiectasis defined by HRCT scanning obtained since 1996. In this review, the authors suggest redefining non-cystic fibrosis bronchiectasis in the context of a spectrum of chronic suppurative lung disease. This paradigm potentially may also apply to CF bronchiectasis.
30. Dakin CJ, Pereira JK, Henry RL, et al.: Relationship between sputum inflammatory markers, lung function, and lung pathology on high-resolution computed tomography in children with cystic fibrosis. Pediatr Pulmonol 2002, 33:475-482.
31. King GG, Muller NL, Whittall KP, et al.: An analysis algorithm for measuring airway lumen and wall areas from high-resolution computed tomographic data. Am J Respir Crit Care Med 2000, 161:574-580.
32. King GG, Muller NL, Pare PD: Evaluation of airways in obstructive pulmonary disease using high-resolution computed tomography. Am J Respir Crit Care Med 1999, 159:992-1004.
33. Nakano Y, Whittall KP, Kalloger SE, et al.: Development and validation of human airway analysis algorithm using multidetector row CT. SPIE 2002, 4683:460-469.
34. Nakano Y, Muller NL, King GG, et al.: Quantitative assessment of airway remodeling using high-resolution CT. Chest 2002, 122(suppl):271S-275S. This article reviews the state of the art techniques for obtaining quantitative HRCT airway measurements to assess and quantify the extent of airway remodeling in asthma and chronic obstructive pulmonary disease patients.
35. Bonnel AS, Song SM, Kesavarju K, et al.: Quantitative air trapping analysis in children with mild cystic fibrosis lung disease. Pediatr Pulmonol 2004, in press. This comparative HRCT study evaluated quantitative air trapping and pulmonary function measurements in 10 CF children with mild obstructive lung disease compared with 10 normal aged-matched controls. Quantitative air trapping measurements revealed significantly lower expiratory lung density and significantly higher air trapping (percent) in the CF children compared to age-matched normals. Pulmonary density measurements and percent air trapping better discriminated differences between groups than PFTs.
36. Long FR, Williams RS, Castile RG: Structural airway abnormalities in infants and young children with cystic fibrosis. J Pediatr 2004, 144:154-161. This comparative HRCT imaging study demonstrated that infants and young children with CF have significantly thicker and more dilated bronchial airways compared to normal infants. This is the first published study utilizing manual quantitative airway measurements as primary outcome measures.
37. Robinson TE, Goris ML, Zhu HJ, et al.: Changes in quantitative air trapping, pulmonary function, and chest HRCT scores in CF children during a Pulmozyme intervention study. Chest 2004; Submitted September 2004. This 1-year randomized, placebo-controlled study of inhaled dornase alfa revealed significant decreases in quantitative HRCT air trapping at 3 months and nearly statistical differences at 12 months of dornase alfa therapy despite limited numbers of subjects evaluated at 1-year follow-up. It is the first study of its kind to incorporate computer-generated quantitative CT outcome measures during a therapeutic intervention in CF subjects.